These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25092225)

  • 21. Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers.
    von Mach MA; Brinkmann C; Hansen T; Weilemann LS; Beyer J
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):416-9. PubMed ID: 12518253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
    Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
    Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
    Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
    Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
    Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
    Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial.
    Thabit H; Hartnell S; Allen JM; Lake A; Wilinska ME; Ruan Y; Evans ML; Coll AP; Hovorka R
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):117-124. PubMed ID: 27836235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative analysis of subcutaneous Lispro and regular insulin injections for stress hyperglycemia: a pilot numerical study.
    Strilka RJ; Armen SB; Indeck MC
    J Theor Biol; 2014 Sep; 356():192-200. PubMed ID: 24769252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin Bolus Administration in Insulin Pump Therapy: Effect of Bolus Delivery Speed on Insulin Absorption from Subcutaneous Tissue.
    Regittnig W; Urschitz M; Lehki B; Wolf M; Kojzar H; Mader JK; Ellmerer M; Pieber TR
    Diabetes Technol Ther; 2019 Jan; 21(1):44-50. PubMed ID: 30620643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bihormonal closed-loop artificial pancreas for type 1 diabetes.
    El-Khatib FH; Russell SJ; Nathan DM; Sutherlin RG; Damiano ER
    Sci Transl Med; 2010 Apr; 2(27):27ra27. PubMed ID: 20393188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog
    Leohr J; Dellva MA; Coutant DE; LaBell E; Heise T; Andersen G; Zijlstra E; Hermanski L; Nosek L; Linnebjerg H
    Clin Pharmacokinet; 2020 Dec; 59(12):1601-1610. PubMed ID: 32468448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of Faster and Standard Insulin Aspart During Fully Closed-Loop Insulin Delivery in Type 2 Diabetes.
    Herzig D; Dehais J; Prost JC; Nakas CT; Stettler C; Bally L; Hovorka R
    Diabetes Technol Ther; 2020 Sep; 22(9):691-696. PubMed ID: 31999478
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation.
    Haidar A; Duval C; Legault L; Rabasa-Lhoret R
    J Diabetes Sci Technol; 2013 Nov; 7(6):1507-12. PubMed ID: 24351176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjusting Therapy Profiles When Switching to Ultra-Rapid Lispro in an Advanced Hybrid Closed-Loop System: An in Silico Study.
    Colmegna P; Diaz C JL; Garcia-Tirado J; DeBoer MD; Breton MD
    J Diabetes Sci Technol; 2024 May; 18(3):676-685. PubMed ID: 36424765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study.
    Gagnon-Auger M; du Souich P; Baillargeon JP; Martin E; Brassard P; Ménard J; Ardilouze JL
    Diabetes Care; 2010 Dec; 33(12):2502-7. PubMed ID: 20841613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes.
    Norman JJ; Brown MR; Raviele NA; Prausnitz MR; Felner EI
    Pediatr Diabetes; 2013 Sep; 14(6):459-65. PubMed ID: 23517449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An insulin infusion advisory system for type 1 diabetes patients based on non-linear model predictive control methods.
    Zarkogianni K; Mougiakakou SG; Prountzou A; Vazeou A; Bartsocas CS; Nikita KS
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5972-5. PubMed ID: 18003374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lispro administered by the QS-M Needle-Free Jet Injector generates an earlier insulin exposure.
    Hu J; Shi H; Zhao C; Li X; Wang Y; Cheng Q; Goswami R; Zhen Q; Mei M; Song Y; Yang S; Li Q
    Expert Opin Drug Deliv; 2016 Sep; 13(9):1203-7. PubMed ID: 27267431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon.
    Jacobs PG; El Youssef J; Castle JR; Engle JM; Branigan DL; Johnson P; Massoud R; Kamath A; Ward WK
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():397-400. PubMed ID: 22254332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes.
    Hovorka R; Canonico V; Chassin LJ; Haueter U; Massi-Benedetti M; Orsini Federici M; Pieber TR; Schaller HC; Schaupp L; Vering T; Wilinska ME
    Physiol Meas; 2004 Aug; 25(4):905-20. PubMed ID: 15382830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.